Insulin administration is essential for managing diabetes mellitus, a condition marked by impaired glucose regulation. However, traditional subcutaneous injections are associated with challenges such as patient discomfort, low compliance, and potential infection. Oral insulin delivery offers a promising alternative, but the insulin vulnerability to degradation in the stomach acidic environment complicates its effectiveness. Developing a reliable oral delivery system remains a significant scientific and medical challenge.
This work investigates a novel approach to solve this problem through the development of polysaccharide core-shell aerogels for oral insulin delivery. These aerogels present a mesoporous structure to load higher amount of insulin than other porous formulations. Also, the coatings prevent the insulin from gastric degradation and enable targeted release in the intestine.
The article entitled “Core-shell aerogel design for enhanced oral insulin delivery“ was published in the International Journal of Pharmaceutics (IF: 5.3, January 2025). This study represents a collaboration with the Middle East Technical University (METU), located in Ankara (Turkey), where AerogelsLab provided the equipment and the knowledge to develop the aerogel formulations. This approach offers a step forward in overcoming the limitations of current insulin therapies.
Recent Comments